恒瑞医药:2022年员工持股计划第三个锁定期实际解锁股份共计283.03万股

Core Points - Heng Rui Medicine (600276)(01276) announced that as of the date of this announcement, a total of 2.8303 million shares from the 2022 employee stock ownership plan have been unlocked during the third lock-up period, accounting for 0.04% of the company's total share capital [1] - As of November 14, 2025, 1.6568 million shares will be transferred to the holders of the employee stock ownership plan through non-trading transfer, while 1.1735 million shares will be sold through centralized bidding [1] - The management committee of the 2022 employee stock ownership plan will carry out corresponding asset distribution work based on the relevant agreements of this employee stock ownership plan [1]

Hengrui Pharma-恒瑞医药:2022年员工持股计划第三个锁定期实际解锁股份共计283.03万股 - Reportify